Effect of Moringa leaves in Cervical cancer patients.

To study the efficacy and safety of Shigru (Moringa oleifera Lam.) patra to improve the haemoglobin level in cervical cancer - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062653

Enrollment

100

Registered

2024-02-14

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Non metastatic cervical cancer patients Hemoglobin level between 7-10.9 gm/dl Serum ferritin level less than 30mcg/L

Exclusion criteria

Exclusion criteria: Any other form of anemia Patient with known chronic ailments like cardiac disorders, chronic infections Known allergy to Iron and related products Known liver and kidney disorders Those who have not completed all the investigations as proposed

Design outcomes

Primary

Measure	Time frame
Mean hemoglobin at the end of interventionTimepoint: 30 days	—

Secondary

Measure	Time frame
Proportion of participants with Hb more than or equal to 11gm/dl Mean change in RBC indices and Iron indices proportion of participants achieving normal RBC indices and iron indices Incidence of any adverse events Compliance to treatment Change in quality of lifeTimepoint: 30 days	—

Countries

India

Contacts

Public ContactAnukul Chandra Kar

Institute of Medical Sciences Banaras Hindu University

karanukul@rediffmail.com9415381727

Outcome results